Dermatitis, Atopic: all 1,444 studies

Page 13 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
• Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsWithdrawnNCT02144142Phase 2
• Pilot Tape Harvesting StudyCompletedNCT02125695
• ADRN Barrier/Immunoprofiling Exploratory Pilot StudyCompletedNCT02115399
• Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic DermatitisCompletedNCT02103972Not applicable
• A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
• Investigating Immune Mechanisms in Atopic EczemaWithdrawnNCT02102841Not applicable
• Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 FragmentsCompletedNCT02098551
• Placebo Effect in the Treatment of Atopic DermatitisCompletedNCT02094287Not applicable
• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedNCT02094235Phase 1/2
• S. Aureus Colonization in Atopic DermatitisCompletedNCT02091037
• Accessible and Affordable Moisturizers for Atopic EczemaCompletedNCT02084472Not applicable
• Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic EczemaCompletedNCT02079688Phase 2
• Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® RegimenCompletedNCT02073591
• A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their FamiliesWithdrawnNCT02067234Not applicable
• Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization DeterminationCompletedNCT02058186Not applicable
• Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%TerminatedNCT02031445Phase 2
• The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo StudyCompletedNCT02028546Not applicable
• Phase 2 Study of KHK4577CompletedNCT02004119Phase 2
• Impact of Vitamin D Supplementation on Severity of Pediatric Atopic DermatitisCompletedNCT01996423Not applicable
• Bleach Bath Treatment of Adults With Atopic DermatitisCompletedNCT01996150Not applicable
• The Effect of Anti-CεmX on IgE ProductionCompletedNCT01995747
• A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisCompletedNCT01993420Phase 2
• Examination of Whether Host Preconditioning Modifies Short-term Transplant SurvivalWithdrawnNCT01960764Phase 1
• Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic DermatitisCompletedNCT01948869Not applicable
• The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic DermatitisWithdrawnNCT01936194Not applicable
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)CompletedNCT01927705Phase 1/2
• Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private PaediatriciansCompletedNCT01920464
• Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic DermatitisCompletedNCT01902836Phase 2
• Evaluation of an Integrated Care ProjectCompletedNCT01854580
• An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
• A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand EczemaTerminatedNCT01826630Not applicable
• An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01826461Phase 2
• A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic DermatitisCompletedNCT01808157Phase 2
• PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic DiseasesStatus unknownNCT01805635
• Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic DermatitisCompletedNCT01792713Phase 2
• Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis PatientsCompletedNCT01789619
• An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
• Defining the Skin and Blood Biomarkers of Pediatric Atopic DermatitisActive, not recruitingNCT01782703
• Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)Status unknownNCT01781663Phase 4
• Emollients in the Management of Atopic DermatitisCompletedNCT01779258Phase 3
• Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in ChildrenTerminatedNCT01772056Phase 3
• Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
• A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema PatientsCompletedNCT01714245
• A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic DermatitisCompletedNCT01702181Phase 1
• Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis PatientsWithdrawnNCT01695707Not applicable
• KM110329 in Adult Patients With Atopic DermatitisStatus unknownNCT01692093Phase 2
• Efficacy/Safety Study to Explore a New Topical Formulation in Atopic DermatitisWithdrawnNCT01691209Not applicable
• Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic DermatitisStatus unknownNCT01689805
• Single Center Study Using Omalizumab in Subjects With Atopic DermatitisCompletedNCT01678092Phase 1
• A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic DermatitisCompletedNCT01675232Not applicable
• Investigation of Topical SB705498 on Healthy VolunteersCompletedNCT01673529Phase 1
• Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis ManagementCompletedNCT01660217Not applicable
• Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic DermatitisCompletedNCT01638234Phase 2/3
• Probiotics and Allergic DiseasesCompletedNCT01635738Not applicable
• A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisCompletedNCT01614756Phase 1
• Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic DermatitisTerminatedNCT01605708Phase 1/2
• Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic DermatitisCompletedNCT01597817Phase 2
• Narrowband UVB for Children With Moderate to Severe Atopic EczemaCompletedNCT01569906
• Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic DermatitisCompletedNCT01568489Phase 2
• A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis PatientsCompletedNCT01552629Phase 2
• Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in PsoriasisCompletedNCT01538342Not applicable
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine PilotCompletedNCT01518478Early Phase 1
• Probiotics in Adults: do They Improve Atopic Dermatitis?CompletedNCT01500941Phase 3
• A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic DermatitisTerminatedNCT01497119Phase 2
• Registry for the Atopic Dermatitis Research NetworkCompletedNCT01494142
• Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic DermatitisCompletedNCT01475994Not applicable
• Sublingual Immunotherapy in Patients With Atopic DermatitisCompletedNCT01471119Phase 2
• Efficacy Emollient on Xerosis in Children With Atopic DermatitisCompletedNCT01467362Phase 3
• A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedNCT01461941Phase 2
• Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.TerminatedNCT01447758Phase 1
• Systemic Therapies for Pediatric Atopic DermatitisStatus unknownNCT01447381
• Interferon Responses in Eczema HerpeticumCompletedNCT01429311
• A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton SyndromeCompletedNCT01428297Phase 1
• HPA Axis Study in AdultsCompletedNCT01408511Phase 2
• HPA Axis Study in Japanese AdultsCompletedNCT01407510Phase 2
• Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic DermatitisTerminatedNCT01402414Not applicable
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic DermatitisCompletedNCT01385657Phase 1
• Pediatric Atopic Dermatitis (AD) Internet SurveyWithdrawnNCT01385527Not applicable
• A Study Assessing GW870086's Potential to Cause Skin ThinningCompletedNCT01381445Phase 1
• Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)CompletedNCT01359787Phase 2
• Effect of Dietary Phospholipids on Atopic DermatitisCompletedNCT01326520Not applicable
• Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic DermatitisCompletedNCT01320579Phase 2
• Chemokine Expression in Nummular Dermatitis and Atopic DermatitisStatus unknownNCT01311986
• Climatotherapy At The Dead Sea For Atopic DermatitisStatus unknownNCT01307150
• Dilute Bleach Baths in Pediatric Patients With Atopic DermatitisTerminatedNCT01286220Not applicable
• Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic DermatitisCompletedNCT01259323Phase 1
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)CompletedNCT01244230Phase 2/3
• Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic DermatitisCompletedNCT01238263
• Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic DermatitisTerminatedNCT01234909
• Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsCompletedNCT01232985Phase 2
• Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic DermatitisCompletedNCT01232543Phase 2
• Management of Eczema by Specific Probiotic StrainsWithdrawnNCT01230190Phase 3
• Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)CompletedNCT01228513Phase 2
• Effect of Probiotics in the Atopic DermatitisCompletedNCT01224132Phase 3
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin InfectionCompletedNCT01223222Phase 2
• Text Messaging and Atopic DermatitisCompletedNCT01216059Not applicable
• Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisCompletedNCT01202149Phase 4
• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2

← Dermatitis, Atopic overview